Renee Heffron1, Deborah Donnell, James Kiarie, Helen Rees, Kenneth Ngure, Nelly Mugo, Edwin Were, Connie Celum, Jared M Baeten. 1. *Department of Global Health, University of Washington, Seattle, WA; †Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; ‡Department of Obstetrics & Gynaecology, University of Nairobi, Nairobi, Kenya; §Wits Reproductive Health and HIV Institute (WRHI), University of the Witwatersrand, Johannesburg, South Africa; ‖Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya; ¶Kenya Medical Research Institute, Nairobi, Kenya; #Department of Reproductive Health, Moi University, Eldoret, Kenya; and **Departments of †Epidemiology and ††Medicine, University of Washington, Seattle, WA.
Abstract
BACKGROUND: In HIV-1-infected women, CD4 count declines occur during pregnancy, which has been attributed to hemodilution. However, for women who have not initiated antiretroviral therapy, it is unclear if CD4 declines are sustained beyond pregnancy and accompanied by increased viral levels, which could indicate an effect of pregnancy on accelerating HIV-1 disease progression. METHODS: In a prospective study among 2269 HIV-1-infected antiretroviral therapy-naive women from 7 African countries, we examined the effect of pregnancy on HIV-1 disease progression. We used linear mixed models to compare CD4 counts and plasma HIV-1 RNA concentrations between pregnant, postpartum, and nonpregnant periods. RESULTS:Women contributed 3270 person-years of follow-up, during which time 476 women became pregnant. In adjusted analysis, CD4 counts were an average of 56 (95% confidence interval: 39 to 73) cells/mm lower during pregnant compared with nonpregnant periods and 70 (95% confidence interval: 53 to 88) cells/mm lower during pregnant compared with postpartum periods; these results were consistent when restricted to the subgroup of women who became pregnant. Plasma HIV-1 RNA concentrations were not different between pregnant and nonpregnant periods (P = 0.9) or pregnant and postpartum periods (P = 0.3). Neither CD4 counts nor plasma HIV-1 RNA levels were significantly different in postpartum compared with nonpregnant periods. CONCLUSIONS:CD4 count declines among HIV-1-infected women during pregnancy are temporary and not sustained in postpartum periods. Pregnancy does not have a short-term impact on plasma HIV-1 RNA concentrations.
RCT Entities:
BACKGROUND: In HIV-1-infectedwomen, CD4 count declines occur during pregnancy, which has been attributed to hemodilution. However, for women who have not initiated antiretroviral therapy, it is unclear if CD4 declines are sustained beyond pregnancy and accompanied by increased viral levels, which could indicate an effect of pregnancy on accelerating HIV-1 disease progression. METHODS: In a prospective study among 2269 HIV-1-infected antiretroviral therapy-naive women from 7 African countries, we examined the effect of pregnancy on HIV-1 disease progression. We used linear mixed models to compare CD4 counts and plasma HIV-1 RNA concentrations between pregnant, postpartum, and nonpregnant periods. RESULTS:Women contributed 3270 person-years of follow-up, during which time 476 women became pregnant. In adjusted analysis, CD4 counts were an average of 56 (95% confidence interval: 39 to 73) cells/mm lower during pregnant compared with nonpregnant periods and 70 (95% confidence interval: 53 to 88) cells/mm lower during pregnant compared with postpartum periods; these results were consistent when restricted to the subgroup of women who became pregnant. Plasma HIV-1 RNA concentrations were not different between pregnant and nonpregnant periods (P = 0.9) or pregnant and postpartum periods (P = 0.3). Neither CD4 counts nor plasma HIV-1 RNA levels were significantly different in postpartum compared with nonpregnant periods. CONCLUSIONS:CD4 count declines among HIV-1-infectedwomen during pregnancy are temporary and not sustained in postpartum periods. Pregnancy does not have a short-term impact on plasma HIV-1 RNA concentrations.
Authors: Billy N Mayanja; Leigh Anne Shafer; Lieve Van der Paal; Nassim Kyakuwa; Nicaise Ndembi; Peter Hughes; Dermot Maher; Heiner Grosskurth Journal: Trop Med Int Health Date: 2011-12-30 Impact factor: 2.622
Authors: Ronald H Gray; Xianbin Li; Godfrey Kigozi; David Serwadda; Heena Brahmbhatt; Fred Wabwire-Mangen; Fred Nalugoda; Mohamed Kiddugavu; Nelson Sewankambo; Thomas C Quinn; Steven J Reynolds; Maria J Wawer Journal: Lancet Date: 2005-10-01 Impact factor: 79.321
Authors: Nelly R Mugo; Renee Heffron; Deborah Donnell; Anna Wald; Edwin O Were; Helen Rees; Connie Celum; James N Kiarie; Craig R Cohen; Kayitesi Kayintekore; Jared M Baeten Journal: AIDS Date: 2011-09-24 Impact factor: 4.177
Authors: Benjamin H Chi; Michelle R Adler; Omotayo Bolu; Dorothy Mbori-Ngacha; Didier K Ekouevi; Anna Gieselman; Tsungai Chipato; Chewe Luo; B Ryan Phelps; Craig McClure; Lynne M Mofenson; Jeffrey S A Stringer Journal: J Acquir Immune Defic Syndr Date: 2012-08-15 Impact factor: 3.731
Authors: Howard Minkoff; Ron Hershow; D Heather Watts; Margaret Frederick; Irene Cheng; Ruth Tuomala; Jane Pitt; Carmen D Zorrilla; Hunter Hammill; Samuel K Adeniyi-Jones; Bruce Thompson Journal: Am J Obstet Gynecol Date: 2003-08 Impact factor: 8.661
Authors: Luiz Fernando Almeida Machado; Iran Barros Costa; Maria Nazaré Folha; Anderson Levy Bessa da Luz; Antonio Carlos Rosário Vallinoto; Ricardo Ishak; Marluisa Oliveira Guimarães Ishak Journal: BMC Infect Dis Date: 2017-04-12 Impact factor: 3.090
Authors: Kristin M Wall; Wasima Rida; Lisa B Haddad; Anatoli Kamali; Etienne Karita; Shabir Lakhi; William Kilembe; Susan Allen; Mubiana Inambao; Annie H Yang; Mary H Latka; Omu Anzala; Eduard J Sanders; Linda-Gail Bekker; Vinodh A Edward; Matt A Price Journal: Epidemiology Date: 2017-03 Impact factor: 4.822
Authors: James Kimani; Charlotte Warren; Timothy Abuya; Richard Mutemwa; Susannah Mayhew; Ian Askew Journal: BMC Public Health Date: 2015-09-17 Impact factor: 3.295
Authors: Susannah H Mayhew; Manuela Colombini; James Kelly Kimani; Keith Tomlin; Charlotte E Warren; Richard Mutemwa Journal: BMC Public Health Date: 2017-07-05 Impact factor: 3.295